In the gene-array experiments using PC-3 (a wild type human prostate carcinoma cell line) clones, silencing FGL2 remarkable downregulates FGF-2, thus inhibiting the occurrence of prostate cancer in mice 36. Here, FGL2 is linked to prostate carcinoma.